[go: up one dir, main page]

BRPI0406832A - Método de reduzir o crescimento de pêlos em um ser humano, uso de um conjugado de alfa-difluorometilornitina ou um sal farmaceuticamente aceitável do mesmo, composto, composição, e, uso de um composto - Google Patents

Método de reduzir o crescimento de pêlos em um ser humano, uso de um conjugado de alfa-difluorometilornitina ou um sal farmaceuticamente aceitável do mesmo, composto, composição, e, uso de um composto

Info

Publication number
BRPI0406832A
BRPI0406832A BR0406832-7A BRPI0406832A BRPI0406832A BR PI0406832 A BRPI0406832 A BR PI0406832A BR PI0406832 A BRPI0406832 A BR PI0406832A BR PI0406832 A BRPI0406832 A BR PI0406832A
Authority
BR
Brazil
Prior art keywords
compound
conjugate
hair growth
difluoromethylornithine
human
Prior art date
Application number
BR0406832-7A
Other languages
English (en)
Inventor
Anwar Jardien
Roman Rariy
Gurpreet S Ahluwalia
Douglas Shander
Original Assignee
Gillette Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gillette Co filed Critical Gillette Co
Publication of BRPI0406832A publication Critical patent/BRPI0406832A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/69—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing fluorine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth
    • A61Q7/02—Preparations for inhibiting or slowing hair growth
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/02—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups
    • C07C251/20—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups being part of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/68—One oxygen atom attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/34—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only
    • C07D311/36—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 3 only not hydrogenated in the hetero ring, e.g. isoflavones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58—Radicals substituted by nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)

Abstract

"MéTODO DE REDUZIR O CRESCIMENTO DE PêLOS EM UM SER HUMANO, USO DE UM CONJUGADO DE ALFADIFLUOROMETILORNITINA OU UM SAL FARMACEUTICAMENTE ACEITáVEL DO MESMO, COMPOSTO, COMPOSIçãO, E, USO DE UM COMPOSTO". Composições incluindo um conjugado de <244>difluorometilornitina podem ser aplicados topicamente para reduzir o crescimento de pêlos.
BR0406832-7A 2003-03-26 2004-03-24 Método de reduzir o crescimento de pêlos em um ser humano, uso de um conjugado de alfa-difluorometilornitina ou um sal farmaceuticamente aceitável do mesmo, composto, composição, e, uso de um composto BRPI0406832A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/397,132 US7015349B2 (en) 2003-03-26 2003-03-26 Reduction of hair growth
PCT/US2004/008928 WO2004087083A2 (en) 2003-03-26 2004-03-24 Reduction of hair growth

Publications (1)

Publication Number Publication Date
BRPI0406832A true BRPI0406832A (pt) 2005-12-27

Family

ID=32988952

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0406832-7A BRPI0406832A (pt) 2003-03-26 2004-03-24 Método de reduzir o crescimento de pêlos em um ser humano, uso de um conjugado de alfa-difluorometilornitina ou um sal farmaceuticamente aceitável do mesmo, composto, composição, e, uso de um composto

Country Status (9)

Country Link
US (2) US7015349B2 (pt)
EP (1) EP1605904A2 (pt)
AR (1) AR043918A1 (pt)
AU (1) AU2004226467A1 (pt)
BR (1) BRPI0406832A (pt)
CA (1) CA2512076A1 (pt)
CO (1) CO5611088A2 (pt)
MX (1) MXPA05008311A (pt)
WO (1) WO2004087083A2 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050220734A1 (en) * 2004-04-02 2005-10-06 Allergan, Inc. Therapy for melanin related afflictions
US7618956B2 (en) * 2005-05-31 2009-11-17 The Gillette Company Reduction of hair growth
EP1893629A4 (en) * 2005-06-22 2008-12-17 Myriad Genetics Inc ANTIVIRAL CONNECTIONS
US20070059264A1 (en) * 2005-09-13 2007-03-15 Ahluwalia Gurpreet S Reduction of hair growth
US7727516B2 (en) * 2006-02-28 2010-06-01 The Procter & Gamble Company Reduction of hair growth
US20090105203A1 (en) * 2006-10-16 2009-04-23 Myriad Genetics, Incorporated Compounds for treating viral infections
US20100120727A1 (en) * 2008-11-12 2010-05-13 Kyphia Pharmaceuticals, Inc. Eflornithine Prodrugs, Conjugates and Salts, and Methods of Use Thereof
CA2742846A1 (en) * 2008-11-17 2010-05-20 Enzon Pharmaceuticals, Inc. Releasable fusogenic lipids for nucleic acids delivery systems
CA3213470A1 (en) * 2008-12-04 2010-06-10 Chongxi Yu High penetration compositions and their applications
WO2012083178A1 (en) * 2010-12-17 2012-06-21 Neo Oncology Inc. Methods and devices for using isoperillyl alcohol
CN105078973B (zh) 2010-08-27 2020-10-09 尼昂克技术公司 包含poh衍生物的药物组合物
US20160038600A1 (en) 2012-08-03 2016-02-11 Neonc Technologies Inc. Pharmaceutical compositions comprising poh derivatives
ES3046537T3 (en) 2016-11-08 2025-12-02 Regeneron Pharma Steroids and protein-conjugates thereof
IL270594B2 (en) 2017-05-18 2024-06-01 Regeneron Pharma Cyclodextrin protein drug conjugates
SG11202004151YA (en) 2017-11-07 2020-06-29 Regeneron Pharma Hydrophilic linkers for antibody drug conjugates
IL319417A (en) 2018-01-08 2025-05-01 Regeneron Pharma Steroids and their anti-inflammatory properties
CN112533951A (zh) 2018-05-09 2021-03-19 里珍纳龙药品有限公司 抗msr1抗体及其使用方法
EP3793522A4 (en) * 2018-06-23 2022-03-02 Cellix Bio Private Limited COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATORY SKIN DISEASES AND CANCER

Family Cites Families (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3426137A (en) 1965-12-23 1969-02-04 Olin Mathieson Hair growth inhibiting by aminobenzophenones
US4161540A (en) 1966-08-22 1979-07-17 Schering Corporation Antiandrogenic agents and methods for the treatment of androgen dependent disease states
GB1458349A (en) 1972-12-05 1976-12-15 Sykora F Composition for and a process therewith of treating the hair and/or scalps of animals
US4039669A (en) 1975-08-01 1977-08-02 Sterling Drug Inc. Composition for topical application and use thereof
US4139638A (en) 1976-09-23 1979-02-13 Schering Corporation Methods for the treatment of hirsutism
FR2380775A1 (fr) 1977-02-22 1978-09-15 Sederma Sarl Composition " apres-epilation " favorisant un ralentissement progressif de la repousse des poils
CA1091661A (en) 1977-07-11 1980-12-16 Philippe Bey .alpha.-HALOMETHYL DERIVATIVES OF .alpha.-AMINO ACIDS
US4191775A (en) 1977-12-15 1980-03-04 Imperial Chemical Industries Limited Amide derivatives
US4269831A (en) 1979-05-09 1981-05-26 Sterling Drug Inc. Topical dermatological method of use of an androstenopyrazole
JP2519024B2 (ja) 1982-06-07 1996-07-31 花王株式会社 毛髪化粧料
US4508714A (en) 1983-11-14 1985-04-02 Tihomir Cecic Organic scalp lotion
US4885289A (en) 1983-12-12 1989-12-05 Breuer Miklos M Alteration of character of male beard growth
US4720489A (en) 1984-10-15 1988-01-19 Douglas Shander Hair growth modification with ornithine decarboxylase inhibitors
US4935231A (en) 1985-08-28 1990-06-19 Repligen Corporation Use of thioredoxin, thioredoxin-derived, or thioredoxin-like dithiol peptides in hair care preparations
US5096911A (en) 1990-06-25 1992-03-17 Ahluwalia Gurpreet S Alteration of rate and character of hair growth
DE69128034T2 (de) * 1990-08-14 1998-04-16 Handelman Joseph H Enzymatische änderung des haarwuchses
US5189212A (en) 1990-09-07 1993-02-23 University Of Georgia Research Foundation, Inc. Triarylethylene carboxylic acids with estrogenic activity
US5095007A (en) 1990-10-24 1992-03-10 Ahluwalia Gurpreet S Alteration of rate and character of hair growth
DE4038693A1 (de) 1990-12-05 1992-06-11 Heverhagen Ulrich Mittel zum reduzieren des wachstums bzw. zum entfernen der haare am menschlichen koerper
US5143925A (en) 1990-12-20 1992-09-01 Douglas Shander Alteration of rate and character of hair growth
GB9118866D0 (en) 1991-09-04 1991-10-23 Unilever Plc Cosmetic composition
GB9118979D0 (en) 1991-09-04 1991-10-23 Unilever Plc Cosmetic composition
US5328686A (en) 1991-10-30 1994-07-12 Douglas Shander Treatment of acne or of pseudofolliculitis barbae
EP0612211B1 (en) 1991-11-05 2002-06-05 The Gillette Company Alteration of rate and character of hair growth
US5364885A (en) 1992-11-13 1994-11-15 Ahluwalia Gurpreet S Reduction of hair growth
US5411991A (en) 1992-12-22 1995-05-02 Shander; Douglas Method of reducing hair growth employing sulfhydryl active compounds
US5648394A (en) 1993-05-27 1997-07-15 Boxall; Brian Alfred Topical composition for inhibiting hair growth
US6239170B1 (en) 1993-05-28 2001-05-29 Gurpreet S. Ahluwalia Inhibition of hair growth
US6248751B1 (en) 1993-05-28 2001-06-19 Gurpreet S. Ahluwalia Inhibition of hair growth
US5362748A (en) 1993-09-15 1994-11-08 The Procter & Gamble Company Methods of using diethyldithiocarbamic acid for the prevention of hair growth
US5474763A (en) 1994-03-11 1995-12-12 Shander; Douglas Reduction of hair growth
US5455234A (en) 1994-03-16 1995-10-03 Ahluwalia; Gurpreet S. Inhibition of hair growth
US5468476A (en) 1994-03-16 1995-11-21 Ahluwalia; Gurpreet S. Reduction of hair growth
US5554608A (en) 1994-09-28 1996-09-10 Ahluwalia; Gurpreet S. Inhibition of hair growth
US5674477A (en) 1995-02-28 1997-10-07 Ahluwalia; Gurpreet S. Reduction of hair growth
AU719106B2 (en) 1995-02-28 2000-05-04 Gillette Company, The Use of angiogenesis suppressors for inhibiting hair growth
US5645825A (en) 1995-06-07 1997-07-08 The Procter & Gamble Company Depilatory compositions comprising sulfhydryl compounds
US5728736A (en) 1995-11-29 1998-03-17 Shander; Douglas Reduction of hair growth
US5652273A (en) 1995-11-30 1997-07-29 Henry; James Reduction of hair growth
ES2196348T3 (es) 1996-07-12 2003-12-16 Johnson & Johnson Consumer Composiciones para retardar el crecimiento del cabello y el uso correspondiente.
US5908867A (en) 1996-07-18 1999-06-01 Henry; James P. Reduction of hair growth
WO1998014188A1 (en) 1996-10-04 1998-04-09 Ilex Oncology, Inc. Dfmo and taxol for the treatment or prevention of breast cancer
US5840752A (en) 1996-11-21 1998-11-24 Henry; James P. Reduction of hair growth
ZA9711121B (en) 1996-12-13 1998-06-23 Handelman Joseph H Reduction of hair growth.
US6037326A (en) 1996-12-31 2000-03-14 Styczynski; Peter Reduction of hair growth
US5939458A (en) 1997-09-22 1999-08-17 Henry; James P. Reduction of hair growth
US5958946A (en) 1998-01-20 1999-09-28 Styczynski; Peter Modulation of hair growth
US6060471A (en) 1998-01-21 2000-05-09 Styczynski; Peter Reduction of hair growth
US6284234B1 (en) 1998-08-04 2001-09-04 Johnson & Johnson Consumer Companies, Inc. Topical delivery systems for active agents
US6020006A (en) 1998-10-27 2000-02-01 The Gillette Company Reduction of hair growth
US6121269A (en) 1999-02-22 2000-09-19 Henry; James P. Reduction of hair growth
US6235737B1 (en) 2000-01-25 2001-05-22 Peter Styczynski Reduction of hair growth
WO2001068076A2 (en) 2000-03-07 2001-09-20 Ilex Oncology, Inc. D-enantiomer of dfmo and methods of use thereof for treating cancer
US6299865B1 (en) 2000-05-02 2001-10-09 Peter Styczynski Reduction of hair growth
DE10117730A1 (de) 2001-04-09 2002-10-10 Basf Ag Umsetzung von (Di)Aminen in Gegenwart einer Lysinoxidase und eines Reduktionsmittels
US20030036561A1 (en) 2001-08-10 2003-02-20 Peter Styczynski Reduction of hair growth
AU2002324699B2 (en) 2001-08-15 2007-07-26 Skinmedica, Inc. Topical composition for follicular delivery of an ornithine decarboxylase inhibitor
US6730809B2 (en) 2001-08-29 2004-05-04 Women First Healthcare, Inc. Processes for the production of α-difluoromethyl ornithine (DFMO)

Also Published As

Publication number Publication date
CA2512076A1 (en) 2004-10-14
US7015349B2 (en) 2006-03-21
MXPA05008311A (es) 2005-09-20
US20060067903A1 (en) 2006-03-30
AU2004226467A1 (en) 2004-10-14
US7345192B2 (en) 2008-03-18
US20040192778A1 (en) 2004-09-30
CO5611088A2 (es) 2006-02-28
AU2004226467A8 (en) 2004-10-14
AR043918A1 (es) 2005-08-17
WO2004087083A2 (en) 2004-10-14
EP1605904A2 (en) 2005-12-21
WO2004087083A3 (en) 2005-05-26

Similar Documents

Publication Publication Date Title
BRPI0406832A (pt) Método de reduzir o crescimento de pêlos em um ser humano, uso de um conjugado de alfa-difluorometilornitina ou um sal farmaceuticamente aceitável do mesmo, composto, composição, e, uso de um composto
BR0012674A (pt) Formulações farmacêuticas preservadas
MY135988A (en) Additive for improving the water resistance of cosmetic or dermatological formulations
MXPA02011912A (es) Composiciones aclaradoras topicas y metodos para su uso.
UY26082A1 (es) Derivados de 1,4-diazabiciclo [3.2.2] nonan-4-carboxilato y -carboxamidas, su preparacion y su aplicacion en terapeutica
AR046933A1 (es) Eficacia de humectacion mejorada mediante el uso de hidroxialquilurea
MXPA02007822A (es) Composicion cosmetica, especialmente para el uso en piel envejecida y/o tensa.
BR0107869A (pt) Composições farmacêuticas eletrogiradas
MY119403A (en) Novel compounds with analgesic effect.
BR0314354A (pt) Formação para gentes lipofìlicos
CY1110061T1 (el) Συνθεσεις περιλαμβανοντας ενωσεις μοδαφινιλης
PT1089704E (pt) Locao tricologica para aplicacao topica
BRPI0412150A (pt) composições para auto-bronzeamento compreendendo um composto de vitamina b3 solúvel em água e um agente de auto-bronzeamento à base de alfa-hidróxi carbonila - composições cosméticas
AU2001284135A1 (en) Use of tyramine in cosmetic compositions to lighten the skin
DE60114168D1 (de) Haarwachstumstimulierende mittel mit verlängerter wirkung
BR0314844A (pt) Novo composto
BR0209619A (pt) Uso de derivados de ciclosporina de posição 3 para crescimento capilar
BR0314843A (pt) Novo composto
CA2571796A1 (en) Cosmetic compositions and methods containing a tanning agent and liposome-enscapsulated ursolic acid
ES2137125A1 (es) La utilizacion de la sal de zinc del acido glicirretico en preparados contra el acne y las composiciones que contienen dicha sal.
BR0211784A (pt) Método para reduzir o crescimento capilar humano, uso de alfa-difluorometilornitina, e composição cosmética usada para a redução do crescimento capilar humano
BR0211778A (pt) Método para reduzir o crescimento capilar humano, composição para a aplicação tópica à pele, uso de uréia, e, método para produzir uma composição para inibir o crescimento capilar de mamìfero
SE9802209D0 (sv) Novel compounds
FR2803513B1 (fr) Utilisation de la dhea et/ou de ses precurseurs ou derives pour ameliorer l&#39;aspect papyrace de la peau
AU2566101A (en) Compounds and methods for the treatment of pain

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.

B15K Others concerning applications: alteration of classification

Ipc: C07D 307/52 (2006.01), A61K 8/44 (2006.01), A61K 8